Standard Biotools | FLDM - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Agilent USD 946M 44M 2025-12
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Bio-Rad Laboratories USD 345.2M 1.8M 2025-12
Bruker USD 379.8M 69.4M 2026-03
Danaher USD 3.59B 375M 2026-03
Illumina USD 721M 38M 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
Nikon Corporation JPY 67.21B 14.78B 2025-06
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Revvity USD 387.66M 34M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
Sony JPY 934.27B 121.78B 2026-03
Standard Biotools USD 11.38M 1.9M 2025-12
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Waters USD 542M 15.42M 2026-03